InspireMD has filed a notice of an exempt offering of securities to raise $40,064,989.00 in New Funding.
According to filings with the U.S. Securities and Exchange Commission, InspireMD is raising up to $40,064,989.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.
About InspireMD
InspireMD (NASDAQ: NSPR) is a commercial-stage medical device company dedicated to helping prevent stroke and save lives. We empower physicians and patients to choose carotid stenting without compromise delivering smart design for stroke prevention through our proprietary MicroNet mesh technology. Uniquely engineered on the outside of the stent scaffold, our mesh is designed to reduce plaque prolapse and provide exceptional neurovascular protection during and after carotid procedures. Our flagship product, CGuard Prime, is the only mesh-covered carotid stent. CGuard is backed by unmatched clinical evidence and over 65,000 stents sold worldwide. Were excited to bring the next generation of carotid stenting to physicians and patients across the United States.
To learn more about InspireMD, visit https://inspiremd.com/
InspireMD Linkedin Page: https://www.linkedin.com/company/inspiremd/
Contact:
Marvin Slosman, President and Chief Executive Officer
888-776-6804
https://www.linkedin.com/in/marvin-slosman-bb2bb917/
SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.
